Showing results (901-910 of 1,218) with videos related to

Sort By:
Pageof 122
The American Journal of Cardiology|March 18, 2014
Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudinZiad A Ali, Shyam Poludasu, Yasir H Qureshi, et al.
American Heart Journal|April 24, 2023
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registryAlessandro Spirito, Won-Joon Koh, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 11, 2020
Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single-center registry studyJonathan Luke Murphy, Nileshkumar Patel, Yuliya Vengrenyuk, et al.
Circulation. Cardiovascular Interventions|September 3, 2021
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk CriteriaMatteo Nardin, Davide Cao, Roxana Mehran, et al.
The American Journal of Cardiology|February 26, 2017
Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary InterventionSerdar Farhan, Usman Baber, Birgit Vogel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 25, 2020
Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary interventionMoritz Blum, Davide Cao, Rishi Chandiramani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2019
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trialAnnapoorna S Kini, George D Dangas, Usman Baber, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Pageof 122